Vera Therapeutics Inc. has announced the allocation of inducement awards to seventeen new employees under its Inducement Plan, as per Nasdaq Listing Rule 5635(c)(4). The awards, approved by the Compensation Committee on June 3, 2025, include non-qualified stock options for 124,000 shares of Class A common stock and restricted stock units (RSUs) for 65,925 shares. The stock options have an exercise price of $30.91, aligning with Vera's closing trading price on the grant date, and will vest over four years. The RSUs will also vest over four years, with specific vesting schedules outlined and contingent on continued employment with Vera.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。